Viewing Study NCT06612268


Ignite Creation Date: 2025-12-24 @ 5:34 PM
Ignite Modification Date: 2026-01-03 @ 8:18 PM
Study NCT ID: NCT06612268
Status: RECRUITING
Last Update Posted: 2025-11-26
First Post: 2024-09-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module